Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Drug Dev Ind Pharm ; 40(6): 730-42, 2014 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-23596972

RESUMO

CONTEXT: Chitosan does not rank highly regarding its employment as tablet filler due to certain limitations. Undesirable properties that limit its utilization as excipient in solid dosage forms include its hydration propensity that negatively affects tablet stability, strength and disintegration. OBJECTIVE: The objective of this study was to investigate the physical stability of chitosan powder, mixtures, granules and tablets under accelerated conditions such as elevated temperatures and humidity over different periods of time. METHODS: Selected physico-chemical properties of pure chitosan powder, physical mixtures of chitosan with Kollidon® VA64 (BASF, Ludwigshafen, Germany), chitosan granules, as well as tablets were evaluated under conditions of elevated humidity and temperature. RESULTS AND DISCUSSION: The physical stability of chitosan tablets exhibited sensitivity towards varying exposure conditions. It was furthermore evident that the presence of moisture (sorbed water) had a marked influence on the physical stability of chitosan powder and tablets. It was evident that the presence of Kollidon® VA64 as well as the method of inclusion of this binder influenced the properties of chitosan tablets. The physical stability of chitosan powder deteriorated to a greater extent compared to that of the chitosan tablets, which were subjected to the same conditions. CONCLUSION: It is recommended that tablets containing chitosan should be stored at a temperature not exceeding 25 °C as well as at a relatively low humidity (<60%) to prevent deterioration of physical properties. Direct compression of chitosan granules which contained 5%w/w Kollidon® VA64 produced the best formulation in terms of physical stability at the different conditions.


Assuntos
Quitosana/química , Excipientes/química , Umidade , Comprimidos , Temperatura , Varredura Diferencial de Calorimetria , Fenômenos Químicos , Composição de Medicamentos , Estabilidade de Medicamentos , Armazenamento de Medicamentos , Dureza , Espectroscopia de Ressonância Magnética , Pós , Espectroscopia de Infravermelho com Transformada de Fourier , Comprimidos/química , Comprimidos/normas , Resistência à Tração , Termogravimetria , Fatores de Tempo , Viscosidade
2.
Curr Drug Deliv ; 10(3): 348-56, 2013 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-23545146

RESUMO

Chitosan is a polymer derived from chitin that is widely available at relatively low cost, but due to compression challenges it has limited application for the production of direct compression tablets. The aim of this study was to use certain process and formulation variables to improve manufacturing of tablets containing chitosan as bulking agent. Chitosan particle size and flow properties were determined, which included bulk density, tapped density, compressibility and moisture uptake. The effect of process variables (i.e. compression force, punch depth, percentage compaction in a novel double fill compression process) and formulation variables (i.e. type of glidant, citric acid, pectin, coating with Eudragit S®) on chitosan tablet performance (i.e. mass variation, tensile strength, dissolution) was investigated. Moisture content of the chitosan powder, particle size and the inclusion of glidants had a pronounced effect on its flow ability. Varying the percentage compaction during the first cycle of a double fill compression process produced chitosan tablets with more acceptable tensile strength and dissolution rate properties. The inclusion of citric acid and pectin into the formulation significantly decreased the dissolution rate of isoniazid from the tablets due to gel formation. Direct compression of chitosan powder into tablets can be significantly improved by the investigated process and formulation variables as well as applying a double fill compression process.


Assuntos
Quitosana/química , Excipientes/química , Antituberculosos/química , Química Farmacêutica , Ácido Cítrico/química , Força Compressiva , Composição de Medicamentos , Isoniazida/química , Tamanho da Partícula , Pectinas/química , Pós , Solubilidade , Comprimidos , Resistência à Tração
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA